BioAro Inc

Published purpose

BioAro is a Canadian AI-Biotech developing AI-guided Precision Medicine through multi-OMICS data analysis, including whole genome (WGS), exome (WES) & microbiome sequencing, cell-free DNA testing, epigenetics & transcriptomics. BioAro’s proprietary AI-driven analytics platform, PanOmiQ, processes this high-dimensional multi-OMICS data for actionable clinical output. These have helped commercialize the BioSport (high performance athletes), BioMYND (mental health) & Biogut (gut wellness & nutrition) programs. BioAro is currently focusing on Drug Development & Discovery, Drug Repurposing & Pharmacogenomics, including in-silico drug design & simulation of clinical trials. BioAro has also built a high performance computing centre